Clinical Trial

Left Roof Linear, Mitral Isthmus Linear and Left Anterior Septal Linear Ablation for Non-paroxysmal AF: PROMISED Trial.

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this prospective randomized study is to assess whether a new treatment strategy consisting of circumferential Pulmonary vein isolation (PVI), left ROof linear (RL), Mitral Isthmus linear (MIL), and left anterior SEptal linear (ASL) ablation and left atrial appendage (LAA) Device occlusion (PROMISED procedure) is superior to the PVI combined LAA closure in enhancing the long-term success rate of catheter ablation in non-paroxysmal atrial fibrillation (AF) patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-01-31.
Trial Details
NCT Number NCT06249347
Lead Sponsor Second Affiliated Hospital of Wenzhou Medical University
Conditions Atrial Fibrillation, Atrial Fibrillation, Persistent
Enrollment 166 participants
Start Date 2024-01-28
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-02-12